Literature DB >> 18490406

Tc2 response at the onset of COPD exacerbations.

Demosthenes Makris1, Stelios Lazarou2, Michael Alexandrakis3, Taxiarchis V Kourelis3, Nikos Tzanakis4, Despina Kyriakou5, Kostas I Gourgoulianis2.   

Abstract

BACKGROUND: T lymphocytes and especially the subpopulations of CD8+ cells are believed to have a key role in COPD pathophysiology, but there are only few data regarding the role of these cells in COPD exacerbation. AIM: We aimed to study prospectively changes of CD8+ T-lymphocyte subpopulations in the sputum of COPD patients at the onset of mild exacerbations and at a stable condition in order to provide further insight in the pathophysiology of the disease.
METHODS: Induced-sputum samples were collected from 24 COPD patients with median age of 52 years (interquartile range [IQR], 44 to 58 years) and FEV(1) percentage of predicted of 78.05% (IQR, 75.8 to 80.1%) at the onset of mild exacerbations not requiring hospitalization and when stable. Inflammatory cells and T-lymphocyte subpopulations (CD4+, CD8+, and cells producing interferon [IFN]-gamma or interleukin [IL]-4) were measured using flow cytometry and immunocytochemical methods.
RESULTS: A significant increase in sputum CD8+ T lymphocytes (p < 0.0001) and significant decreases in CD4+ T lymphocytes as well as in CD4+/CD8+ (p = 0.0001) and CD8+IFN-gamma+/CD8+IL-4+ (p = 0.001), CD4+IFN-gamma+/CD4+IL-4+ (p = 0.0003) sputum cells ratios were found decreased at the onset of exacerbations compared to stable condition. The changes in T-lymphocyte subpopulations were not associated with smoking history, demographic characteristics, or disease severity.
CONCLUSION: The findings of the present study suggest that CD8+ lymphocytes are increased and potentially polarized toward a Tc2 profile in the airways of COPD patients at the onset of COPD exacerbations with respect to stable condition. The clinical impact of the observed phenomenon requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490406     DOI: 10.1378/chest.07-2626

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  IFN-γ-induced JAK/STAT, but not NF-κB, signaling pathway is insensitive to glucocorticoid in airway epithelial cells.

Authors:  Danielle O'Connell; Belaid Bouazza; Blerina Kokalari; Yassine Amrani; Alaa Khatib; John David Ganther; Omar Tliba
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-19       Impact factor: 5.464

2.  IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation.

Authors:  T Southworth; A Metryka; S Lea; S Farrow; J Plumb; D Singh
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

3.  Selective inhibition by simvastatin of IRF3 phosphorylation and TSLP production in dsRNA-challenged bronchial epithelial cells from COPD donors.

Authors:  Angelica Brandelius; Irma Mahmutovic Persson; Jenny Calvén; Leif Bjermer; Carl G A Persson; Morgan Andersson; Lena Uller
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

4.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

Review 5.  Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

6.  14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in TC2 and CD8+ lymphocytes from patients with scleroderma.

Authors:  Sandra Cascio; Thomas A Medsger; William F Hawse; Simon C Watkins; Christine Milcarek; Larry W Moreland; Robert A Lafyatis; Patrizia Fuschiotti
Journal:  J Allergy Clin Immunol       Date:  2017-11-15       Impact factor: 10.793

Review 7.  Immunodeficiency in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Sheling Xie; Kaifei Wang; Wei Zhang; Kun Xiao; Peng Yan; Yanqin Li; Wanxue He; Yuhan Zhang; Lixin Xie
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 8.  Current perspectives on the role of CD8+ T cells in systemic sclerosis.

Authors:  Patrizia Fuschiotti
Journal:  Immunol Lett       Date:  2017-10-05       Impact factor: 3.685

9.  T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease.

Authors:  Manminder Kaur; Lucy Jc Smyth; Paul Cadden; Seamus Grundy; David Ray; Jonathan Plumb; Dave Singh
Journal:  Respir Res       Date:  2012-03-14

10.  COPD exacerbation: lost in translation.

Authors:  Demosthenes Makris; Demosthenes Bouros
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.